Xiumei Peng
Overview
Explore the profile of Xiumei Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
266
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu M, Liu X, Suo P, Gong Y, Qu B, Peng X, et al.
Transl Lung Cancer Res
. 2020 Jul;
9(3):646-658.
PMID: 32676327
Background: Germline variations may contribute to lung cancer susceptibility besides environmental factors. The influence of germline mutations on lung cancer susceptibility and their correlation with somatic mutations has not been...
2.
Yao J, Gong Y, Zhao W, Han Z, Guo S, Liu H, et al.
Sci Rep
. 2019 Nov;
9(1):15767.
PMID: 31673068
POLE/POLD1 gene variants have been suggested as potential markers for immunotherapy due to their significant association with the tumor mutational burden (TMB), an effective indicator for response prediction in immunotherapy....
3.
Qu X, Li Q, Yang J, Zhao H, Wang F, Zhang F, et al.
Front Oncol
. 2019 Oct;
9:931.
PMID: 31608233
Exosomes are cell-derived vesicles and bear a specific set of nucleic acids including DNA (exoDNA). Thus, this study is to explore whether exoDNA in malignant pleural effusions (MPEs) could be...
4.
Peng X, Liu X, Xu L, Li Y, Wang H, Song L, et al.
J Thorac Dis
. 2019 Aug;
11(6):2458-2469.
PMID: 31372283
Background: Instant monitoring of the therapeutic effect of systematic therapy in late-stage lung cancer is crucial for response assessment and strategy adjustment. Previous study found that specific plasma methylation markers...
5.
The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors
Song L, Wang J, Wang H, Chen Y, Jia J, Guo S, et al.
Epigenomics
. 2018 Nov;
10(12):1569-1583.
PMID: 30426784
Aim: To investigate the quantitative relationship between the positive detection rate (PDR) in colorectal tumor detection and the mSEPT9 level. Materials & Methods: The level of blood mSEPT9 in various...
6.
Song L, Guo S, Wang J, Peng X, Jia J, Gong Y, et al.
Biomark Med
. 2018 Jul;
12(9):961-973.
PMID: 30043648
Aim: To investigate the performance of methylated SEPT9 (mSEPT9) in assessing the surgical therapeutic effect and prognosis of colorectal cancer (CRC). Methods: Blood samples before surgery and 1 and 7...
7.
Song L, Jia J, Peng X, Xiao W, Li Y
Sci Rep
. 2017 Jun;
7(1):3032.
PMID: 28596563
The SEPT9 gene methylation assay is the first FDA-approved blood assay for colorectal cancer (CRC) screening. Fecal immunochemical test (FIT), FIT-DNA test and CEA assay are also in vitro diagnostic...
8.
Song L, Peng X, Li Y, Xiao W, Jia J, Dong C, et al.
Epigenomics
. 2017 May;
9(5):599-610.
PMID: 28470092
Aim: This study validated the detection of colorectal adenoma in opportunistic screening using the SEPT9 gene methylation assay. Materials & Methods: Plasma samples including 85 colorectal cancers, 364 adenomas, 216...
9.
Wen Z, Pan Y, Cui Y, Peng X, Chen P, Fan J, et al.
Theriogenology
. 2017 Mar;
93:16-23.
PMID: 28257862
Colony-stimulating factor 2 (CSF) is known to promote the development and survival of rodents and ruminants preimplantation embryos; however, the effect of CSF on yak embryos has not been reported....
10.
Song L, Jia J, Yu H, Peng X, Xiao W, Gong Y, et al.
J Cancer Res Clin Oncol
. 2017 Feb;
143(6):1093-1101.
PMID: 28224298
Purpose: This study aims to examine the influence of algorithm and subject-related factors, including cancer stage, age, sex, and cancer location, on the performance of the SEPT9 gene methylation test,...